Research funder · International
H2020 Health
- Grants since 2016
- 928
- Awarded, last 5 years (where amounts are published)
- €906.8M
- Funded works, last 5 years
- 233
- Funded works, all time
- 522
Grants
2021 · grant · H2020-EU.3.1.
POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment
2021 · grant · H2020-EU.3.1.
European platform for neurodegenerative disorders
2021 · grant · H2020-EU.3.1.
Improving equity in access to early diagnosis of cancer: implementation research in different healthcare systems of Latin America (EquityCancer-LA)
2021 · grant · H2020-EU.3.1.
VACCELERATE - European Corona Vaccine Trial Accelerator Platform
2021 · grant · H2020-EU.3.1.
Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment.
2021 · grant · H2020-EU.3.1.
HEAlthier Cities through Blue-Green Regenerative Technologies: the HEART Approach
2021 · grant · H2020-EU.3.1.
Finding Endometriosis using Machine Learning
2021 · grant · SC1-PHE-CORONAVIRUS-2020-2C
RESpondIng to outbreaks through co-creaTIve sustainable inclusive equality stRatEgies
2021 · grant · H2020-EU.3.1.
Comprehensive Treatment of Chronic Patients in Rural Areas
2021 · grant · H2020-EU.3.1.
Real World Handling of Protein Drugs - Exploration, Evaluation and Education
2021 · grant · H2020-EU.3.1.
Ground-BrEAking Electroporation-based inTervention for Atrial Fibrillation treatment (BEAT AF)
2021 · grant · H2020-EU.3.1.
JPIAMR- ANTIMICROBIAL TRANSMISSION INTERVENTIONS
2021 · grant · H2020-EU.3.1.
Secretariat for the International Consortium for Personalised Medicine (ICPerMed)
2021 · grant · H2020-EU.3.1.
Clinical validation of a continuous flow peritoneal dialysis system, with dialysate regeneration
2021 · grant · H2020-EU.3.1.
Improving COgnition in Down syndrome
2021 · grant · H2020-EU.3.1.
pREVention and management tools for rEducing antibiotic Resistance in high prevalence Settings
2021 · grant · IMI2-2020-22-01
Psychiatric Ratings using Intermediate Stratified Markers 2
2021 · grant · H2020-EU.3.1.
REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi-source data
2021 · grant · H2020-EU.3.1.
Scaling EUROpean citizen driven transferable and transformative digital integrated health and social care
2021 · grant · H2020-EU.3.1.
Human, technical and political factors for better coordination and support of e-health in Africa
2021 · grant · H2020-EU.3.1.
BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe
2021 · grant · H2020-EU.3.1.
European Clinical Research Alliance on Infectious Diseases
2021 · grant · H2020-EU.3.1.
PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN: TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY
2021 · grant · H2020-EU.3.1.
JIU-JITSU WITH MISINFORMATION IN THE AGE OF COVID: USING REFUTATION-BASED LEARNING TO ENHANCE VACCINE UPTAKE AND KNOWLEDGE AMONG HEALTHCARE PROFESSIONALS AND THE PUBLIC
2021 · grant · SC1-BHC-20A-2020
InnovaTIve care services, enhanced with technology, to deliver QUick rEsponses for individuals with advanced heart failure and complex care needs through integrated care
2021 · grant · H2020-EU.3.1.
Plastics fate and effects in the human body
2021 · grant · H2020-EU.3.1.
Toward Precision Toxicology: New Approach Methodologies for Chemical Safety
2021 · grant · H2020-EU.3.1.
Pre-commercial procurement for integrated CARE solutions addressing the Multimorbidity mATRIX in ageing populations
2021 · grant · H2020-EU.3.1.
Individualized CARE for Older Persons with Complex Chronic Conditions at home and in nursing homes
2021 · grant · H2020-EU.3.1.
Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases
2021 · grant · H2020-EU.3.1.
In Silico World: Lowering barriers to ubiquitous adoption of In Silico Trials
2021 · grant · H2020-EU.3.1.
European consortium for communicating gene- and cell-based therapy information.
2021 · grant · H2020-EU.3.1.
PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors
2021 · grant · H2020-EU.3.1.
BRinging Artificial INTelligencE home for a better cAre of amyotrophic lateral sclerosis and multiple SclERosis
2021 · grant · H2020-EU.3.1.
Rituximab in patients with acute myocardial infarction: a phase 2 placebo-controlled randomised clinical trial
2021 · grant · H2020-EU.3.1.
Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine
2021 · grant · H2020-EU.3.1.
International consortium for integrative genomics prediction
2020 · grant · H2020-EU.3.1.
Implementation of early detection and early intervention service delivery in infants at risk for cerebral palsy to promote infants’ psychomotor development and maternal health
2020 · grant · H2020-EU.3.1.
Personalized Prevention for Coronary Heart Disease
2020 · grant · H2020-EU.3.1.